Special Considerations for Antihypertensive Agents in Dialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|29|2|93-98

ISSN： 0253-5068

Source： Blood Purification, Vol.29, Iss.2, 2010-01, pp. : 93-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparison of the Antihypertensive and Anti-Inflammatory Effects of Aliskiren and Ramipril Add-On Therapy in Peritoneal Dialysis Patients – A Pilot Open Label Study

By  

Kidney and Blood Pressure Research, Vol. 36, Iss. 1, 2012-07 ,pp. : 18-25

Karger

Access to resources Recommend Favorite

Tuberculosis in Maintenance Dialysis Patients

By  

Nephron, Vol. 88, Iss. 2, 2001-05 ,pp. : 138-143

Karger

Access to resources Recommend Favorite

Tuberculosis in Active Dialysis Patients in Jeddah

By  

American Journal of Nephrology, Vol. 19, Iss. 1, 1999-03 ,pp. : 34-37

Karger

Access to resources Recommend Favorite

Staphylococcus aureus Prophylaxis in Dialysis Patients

By  

Blood Purification, Vol. 18, Iss. 4, 2000-08 ,pp. : 350-354

Karger

Access to resources Recommend Favorite

Evaluation of Oxidant Stress in Dialysis Patients

By  

Blood Purification, Vol. 18, Iss. 4, 2000-08 ,pp. : 343-349

Karger

Access to resources Recommend Favorite